Home›Companies›Abacus Bioscience

Abacus Bioscience Inc.

Updated Oct 29, 2026·Latest SEC filing Feb 3, 2023·Suggest an edit

About Abacus Bioscience

Abacus Bioscience is a private company based in Sammamish, Washington. It has reported $4,413,591 raised in one offering on Form D since February 2023. Its chief executive is Alan Wahl.

Funding Rounds (SEC Form D)

First saleFiled with SECAmount soldInvestorsAvg. checkTermsFiling
Jan 19, 2023Feb 3, 2023$4,413,591fully sold13$339KEquityRule 506(b)Form D ↗

First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.

Leadership Team

Executive officers and directors listed on Abacus Bioscience's Form D filed Feb 3, 2023.

AW
Alan Wahl
Chief Executive Officer and director
WC
CL

Sources

  1. SECAbacus Bioscience Inc. filing history